Insulin Regimens and Clinical Outcomes in a Type 1 Diabetes Cohort

OBJECTIVE To examine the patterns and associations of insulin regimens and change in regimens with clinical outcomes in a diverse population of children with recently diagnosed type 1 diabetes. RESEARCH DESIGN AND METHODS The study sample consisted of youth with type 1 diabetes who completed a baseline SEARCH for Diabetes in Youth study visit after being newly diagnosed and at least one follow-up visit. Demographic, diabetes self-management, physical, and laboratory measures were collected at study visits. Insulin regimens and change in regimen compared with the initial visit were categorized as more intensive (MI), no change (NC), or less intensive (LI). We examined relationships between insulin regimens, change in regimen, and outcomes including A1C and fasting C-peptide. RESULTS Of the 1,606 participants with a mean follow-up of 36 months, 51.7% changed to an MI regimen, 44.7% had NC, and 3.6% changed to an LI regimen. Participants who were younger, non-Hispanic white, and from families of higher income and parental education and who had private health insurance were more likely to be in MI or NC groups. Those in MI and NC groups had lower baseline A1C (P = 0.028) and smaller increase in A1C over time than LI (P < 0.01). Younger age, continuous subcutaneous insulin pump therapy, and change to MI were associated with higher probability of achieving target A1C levels. CONCLUSIONS Insulin regimens were intensified over time in over half of participants but varied by sociodemographic domains. As more intensive regimens were associated with better outcomes, early intensification of management may improve outcomes in all children with diabetes. Although intensification of insulin regimen is preferred, choice of insulin regimen must be individualized based on the child and family’s ability to comply with the prescribed plan.

[1]  V. Helgeson,et al.  A focus on blood glucose monitoring: relation to glycemic control and determinants of frequency , 2011, Pediatric diabetes.

[2]  J. Rosenbauer,et al.  Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes , 2011, Pediatric diabetes.

[3]  T. Lewis,et al.  Intensive vs. conventional insulin management initiated at diagnosis in children with diabetes: Should payer source influence the choice of therapy? , 2009, Pediatric diabetes.

[4]  D. Petitti,et al.  Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study. , 2009, The Journal of pediatrics.

[5]  J. Silverstein,et al.  In pursuit of lower A1c. , 2009, The Journal of pediatrics.

[6]  W. Hagopian,et al.  Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. , 2009, Clinical immunology.

[7]  J. Ludvigsson The Role of Immunomodulation Therapy in Autoimmune Diabetes , 2009, Journal of diabetes science and technology.

[8]  C. Davis,et al.  Participation in pediatric epidemiologic research: the SEARCH for Diabetes in Youth Study experience. , 2008, Contemporary clinical trials.

[9]  S. Chalew Continuing Stability of Center Differences in Pediatric Diabetes Care: Do Advances in Diabetes Treatment Improve Outcome? The Hvidoere Study Group on Childhood Diabetes , 2008, Diabetes Care.

[10]  C. de Beaufort,et al.  Continuing Stability of Center Differences in Pediatric Diabetes Care: Do Advances in Diabetes Treatment Improve Outcome? , 2007, Diabetes Care.

[11]  David M Nathan,et al.  The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study , 2006, Diabetes.

[12]  B. Anderson,et al.  Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. , 2005, Diabetes care.

[13]  SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. , 2004, Controlled clinical trials.

[14]  E. Arias,et al.  United States Census 2000 population with bridged race categories. , 2003, Vital and health statistics. Series 2, Data evaluation and methods research.

[15]  Shumei S. Guo,et al.  2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.

[16]  Shumei S. Guo,et al.  CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000 , 2002 .

[17]  R. Rubin,et al.  Implications of the DCCT: Looking beyond tight control , 1994, Diabetes Care.